US$ 23.77
retatrutide trial results 2025 news Results: 28.3% Weight Loss Data Retatrutide Achieves Large Weight Decreases
Description
maintain blood sugar stability and enhance metabolic balance

This medication has shown efficacy in the TRIUMPH-1 Phase 3 trial, where participants experienced up to 28.3% weight loss over 80 weeks

Firms with 200 or more workers were asked about the importance of covering GLP-1 agonists for weight loss for employee satisfaction with their health plan

Freezing reconstituted tirzepatide damages the peptide structure through ice crystal formation
It is approved for adults and children 10 years and older

doi: 10.1210/jc.2008-1296
